Inhibitors of collagen-induced platelet aggregation

Details Inhibitors of collagen-induced platelet aggregation Inhibitors of collagen-induced platelet aggregation

A - Human Necessities

61

K

A61K 31/277 (2006.01) A61P 7/02 (2006.01) A61P 9/10 (2006.01)

Patent

CA 2390857

The present invention describes a therapeutic method useful for treating or preventing a condition of platelet aggregation, in a subject including administering a pharmaceutically effective amount of a compound or composition that inhibits BTK and collagen induced platelet aggregation. The condition of platelet aggregation includes cardiovascular, hematopoietic and cerbrovascular diseases.

L'invention concerne une méthode thérapeutique utilisée pour traiter ou prévenir un état pathologique d'agrégation plaquettaire chez un sujet. Cette méthode consiste à administrer une quantité pharmaceutiquement efficace d'un composé ou d'une composition inhibant l'agrégation plaquettaire induite par la tyrosine kinase de Bruton et par le collagène. L'état pathologique d'agrégation plaquettaire englobe les maladies cardio-vasculaires, hématopoïétiques et les maladies vasculaires cérébrales.

Affiliated with

Also associated with

Rating

Inhibitors of collagen-induced platelet aggregation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitors of collagen-induced platelet aggregation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of collagen-induced platelet aggregation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1407056